Low-dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients.

While topical minoxidil has been a mainstay androgenetic alopecia (AGA) treatment, oral minoxidil has only been studied recently. Previous studies indicate low-dose oral minoxidil (LDOM) is an efficacious, well-tolerated AGA therapy, and our study aims to contribute to the growing LDOM literature an analysis of quantitative outcomes at multiple areas of the scalp in one of the largest cohorts reported.